-
公开(公告)号:US20220411505A1
公开(公告)日:2022-12-29
申请号:US17635258
申请日:2020-08-14
Applicant: GENMAB A/S
Inventor: Jesper VALBJOERN , Lene Schantz HARLOW , Jacob Dahlqvist CLAUSEN , Mette Hamborg JENSEN , Christian CIMANDER , Jesper PASS , Peter Juul MADSEN , Shan REN , Maria Anna Cecilia WAHLBOM , Bolette BJERREGAARD
Abstract: The present invention relates to improved pharmaceutical compositions and dosage unit forms of bispecific CD3×CD20 antibodies and to routes of administration.